Full Press Release Details
QUIPT HOME MEDICAL TO PARTICIPATE AT THE SIDOTI
VIRTUAL INVESTOR CONFERENCE ON MARCH 23RD - 24TH
SIDOTI WEBCASTED PRESENTATION TO BE HELD WEDNESDAY
Cincinnati, Ohio - March 15, 2022 -
Quipt Home Medical Corp. (the "Company" or "Quipt") (NASDAQ: QIPT), (TSXV: QIPT) a U.S.
based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that members of its
management team will host a webcasted presentation and participate in 1x1 meetings with institutional investors at the upcoming Sidoti
Virtual Investor Conference on March 23rd - 24th.
Webcasted Presentation
Event: Sidoti Virtual Investor
Date: Wednesday, March 23, 2022
the presentation will be available by visiting the investors' section of the company's website at www.Quipthomemedical.com.
The webcast will also be available for replay on the company's website following the event.
execute on our core strategy focused on driving continued operational execution and integration of recently acquired assets and look forward
to updating the investor community at the Sidoti conference later this month. With a full pipeline of acquisition targets that provide
us the opportunity to continue to scale our operating footprint, we anticipate being very active over the short term, and are extremely
bullish about the outlook for our company," commented Greg Crawford, CEO, and Chairman of Quipt.
ABOUT QUIPT HOME MEDICAL
The Company provides
in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare
market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients
with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective
of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic
disease management. The Company's organic growth strategy is to increase annual revenue per patient by offering multiple services
to the same patient, consolidating the patient's services and making life easier for the patient.
There can be no assurance
that any of the potential acquisitions in the Company's pipeline or in negotiations will be completed as proposed or at all
and no definitive agreements have been executed. Completion of any transaction will be subject to applicable director, shareholder
and regulatory approvals.
Neither the TSX Venture
Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of this release.
Forward-Looking Statements
contained in this press release constitute "forward-looking information" as such term is defined in applicable
Canadian securities legislation. The words "may", "would", "could", "should", "potential",
"will", "seek", "intend", "plan", "anticipate", "believe",
"estimate", "expect" and similar expressions as they relate to the Company, including: the Company's
acquisition plans and potentially completing acquisitions; are intended to identify forward-looking information. All statements
other than statements of historical fact may be forward-looking information. Such statements reflect the Company's
current views and intentions with respect to future events, and current information available to the Company, and
are subject to certain risks, uncertainties and assumptions, including, without limitation: the Company successfully
identifying, negotiating and completing one or more acquisitions, including conditions precedent for such acquisitions being satisfied.
Many factors could cause the actual results, performance or achievements that may be expressed or implied by such
forward- looking information to vary from those described herein should one or more of these risks or uncertainties
materialize. Examples of such risk factors include, without limitation: credit; market (including equity, commodity,
foreign exchange and interest rate); liquidity; operational (including technology and infrastructure); reputational;
insurance; strategic; regulatory; legal; environmental; capital adequacy; the general business and economic conditions
in the regions in which the Company operates; the ability of the Company to execute on key priorities, including
the successful completion of acquisitions, business retention, and strategic plans and to attract, develop and retain
key executives; difficulty integrating newly acquired businesses; the ability to implement business strategies and
pursue business opportunities; low profit market segments; disruptions in or attacks (including cyber-attacks) on
the Company's information technology, internet, network access or other voice or data communications systems or
services; the evolution of various types of fraud or other criminal behavior to which the Company is exposed; the
failure of third parties to comply with their obligations to the Company or its affiliates; the impact of new and
changes to, or application of, current laws and regulations; decline of reimbursement rates; dependence on few payors;
possible new drug discoveries; a novel business model; dependence on key suppliers; granting of permits and licenses
in a highly regulated business; the overall difficult litigation environment, including in the U.S.; increased competition;
changes in foreign currency rates; increased funding costs and market volatility due to market illiquidity and competition
for funding; the availability of funds and resources to pursue operations; critical accounting estimates and changes
to accounting standards, policies, and methods used by the Company; the occurrence of natural and unnatural catastrophic
events and claims resulting from such events; and risks related to COVID-19 including various recommendations,
orders and measures of governmental authorities to try to limit the pandemic, including travel restrictions,
border closures, non-essential business closures, quarantines, self-isolations, shelters-in-place
and social distancing, disruptions to markets, economic activity, financing, supply chains and sales
channels, and a deterioration of general economic conditions including a possible national or global
recession ; as well as those risk factors discussed or referred to in the Company's disclosure documents
filed with the securities regulatory authorities in certain provinces of Canada and available at www.sedar.com.
Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking
information prove incorrect, the actual results or events may differ materially from the results or events
predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary
statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such
forward-looking information. The forward-looking information included in this press release is made as of
the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking
information, other than as required by applicable law.
For further information
please visit our website at www.Quipthomemedical.com, or contact:
VP of Corporate Development
Quipt Home Medical Corp.
Chief Executive Officer
Quipt Home Medical Corp.